Skip to Content
Their letter echoes a recent call from more than 60 civil society organizations
Lawmakers: “the federal government’s commitment to the AI Bill of Rights would show that fundamental rights will not take a back seat in the AI era”
Letter…
Issues:
Science, Technology, & Antitrust
“UnitedHealth Group’s proposed … acquisition of … Amedisys is the latest example of massive health care conglomerates using anticompetitive mergers to increase their market dominance, reducing competition, hurting patients, and increasing health care costs.”
“Blocking anticompetitive deals and rejecting the…
Issues:
Health Care,
Science, Technology, & Antitrust
IG’s Recently Released Investigation, Requested by Lawmakers, Revealed “Possibility of Undue Influence by Former or Prospective Employers” on IRS Officials
Text of Letter (PDF)
Washington, D.C. – United States Representative Pramila Jayapal (D-Wash.) and United States Senator Elizabeth Warren (D-Mass.),…
Issues:
Jobs, Labor, & the Economy,
Science, Technology, & Antitrust
FTC To Hold Open Meeting To Consider Key Policy Statement on Improper Patent Listings
Big Pharma Exploits FDA’s “Orange Book” to Prevent the Entry of Lower-Cost Generics and Block Competition
Text of Letter (PDF)
Washington, D.C. – U.S. Representative Pramila…
Issues:
Health Care,
Science, Technology, & Antitrust
Progressive leaders in Senate and House demand answers from AI CEOs as they’re set to appear in Congress for special briefing
Lawmakers: “Tech companies must not build AI on the backs of exploited workers.”
Text of Letter (PDF)
Washington (September…
Issues:
Jobs, Labor, & the Economy,
Science, Technology, & Antitrust
Washington, D.C. – US. Representative Pramila Jayapal (D-Wash.) and Senator Elizabeth Warren (D-Mass.) sent a letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA), urging him to close loopholes that pharmaceutical companies have exploited to block…
Issues:
Health Care,
Science, Technology, & Antitrust
